KALA BIO, INC. Cash and Cash Equivalents
KALA BIO, INC. (KALA) had Cash and Cash Equivalents of $229.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-19
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $229.00K.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $1.76M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $7.56M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $21.10M.
| Period end | Cash and Cash Equivalents, at Carrying Value |
|---|---|
| 2026-06-30 | $229.00K 10-Q · filed 2026-08-19 |
| 2026-03-31 | $1.76M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $7.56M 10-Q · filed 2026-08-19 |
| 2025-09-30 | $21.10M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $31.94M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $42.22M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $51.18M 10-K · filed 2026-04-15 |
| 2024-09-30 | $49.20M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $54.20M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $48.48M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $50.90M 10-K · filed 2025-03-31 |
| 2023-09-30 | $56.06M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $49.26M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $63.64M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $70.50M 10-K · filed 2024-03-29 |
| 2022-09-30 | $52.39M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $42.57M 10-Q · filed 2023-08-04 |
| 2022-03-31 | $65.17M 10-Q · filed 2023-05-09 |
| 2021-12-31 | $92.14M 10-K · filed 2023-03-03 |
| 2021-09-30 | $124.50M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $144.63M 10-Q · filed 2022-08-11 |
| 2021-03-31 | $127.97M 10-Q · filed 2022-05-16 |
| 2020-12-31 | $77.26M 10-K · filed 2022-03-29 |
| 2020-09-30 | $45.53M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $128.02M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $196.46M 10-Q · filed 2021-05-05 |
| 2019-12-31 | $85.45M 10-K · filed 2021-02-25 |
| 2019-09-30 | $97.56M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $118.01M 10-Q · filed 2020-08-06 |
| 2017-09-30 | $122.05M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $26.35M 10-Q · filed 2017-08-31 |
| 2016-12-31 | $45.47M 10-Q · filed 2017-11-07 |
| 2016-09-30 | $51.88M 10-Q · filed 2017-11-07 |
| 2016-06-30 | $61.08M 10-Q · filed 2017-08-31 |
| 2015-12-31 | $5.76M 10-Q · filed 2017-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |